Associated Papers
Insights into the Mechanism of Paraoxonase-1: Comparing the Reactivity of the Six-Bladed β-Propeller Hydrolases.
Grunkemeyer TJ et al.
Biochemistry, 2024
Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus.
Zhou M et al.
Pediatric Research, 2021
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
Taler-Verčič A et al.
Molecules (basel, Switzerland), 2020
Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
Zhou M et al.
Journal of Diabetes Research, 2020
Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome.
Zhang Y et al.
European Journal of Endocrinology, 2015
Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway.
Koren-Gluzer M et al.
Atherosclerosis, 2013
Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis.
Fuhrman B et al.
Atherosclerosis, 2010
3-D structure of serum paraoxonase 1 sheds light on its activity, stability, solubility and crystallizability.
Harel M et al.
Arhiv Za Higijenu Rada I Toksikologiju, 2007
The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
Rosenblat M et al.
The Journal of Biological Chemistry, 2006
The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases.
Khersonsky O et al.
The Journal of Biological Chemistry, 2006
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.
Harel M et al.
Nature Structural & Molecular Biology, 2004
Select a paper to view details